NorthWest Biotherapeutics Inc (NWBO)

[HappyLibrarian]

This really shows the negative impact on ordinary shareholders of tacking on a journal article to an already protracted process of releasing TLD because we will need another heavy dilution at low prices during this long wait.

No one asked for this article and another delay and this is clearly just more of the same from management because remember they said they expected September 2019 which meant they were either lying because with an article that was impossible or they made pursuing this supposedly essential article a last minute unwelcome addition to the process.